
P055 IMPACT OF NEW BIOLOGIC AGENT APPROVAL FOR ULCERATIVE COLITIS ON TUMOR NECROSIS FACTOR INHIBITOR (TNF) PRESCRIBING: RESULTS FROM A NATIONAL PATIENT CHART AUDIT
Kane, S, Price, LVolume:
24
Langue:
english
Journal:
Inflammatory Bowel Diseases
DOI:
10.1093/ibd/izy019.061
Date:
January, 2018
Fichier:
PDF, 772 KB
english, 2018